Intra-aortic balloon pump in acute myocardial infarction and cardiogenic shock, efficiency, safety and mortality risk factors-Reference-Cited by-同舟云学术

Intra-aortic balloon pump in acute myocardial infarction and cardiogenic shock, efficiency, safety and mortality risk factors

Published:2023-10 Issue:4 Volume:72 Page:101635
ISSN:0003-3928
Container-title:Annales de Cardiologie et d'Angéiologie
language:fr
Short-container-title:Annales de Cardiologie et d'Angéiologie

Author:

Hamdan Righab,Kadri Zena,Abdallah Hadi,Hamadeh Ahmad,Alsaedi Ehab,Al Baba Bassam,Shoka Wael Abo,Yassine Noha,Al Aila Farah,Gafar Salma,Mansour Anoop,Lozon Hadeel,Daka Loai Abo,Soukieh Farah,Hamadi Omar,Jayyousi Waleed Al,Chah Islam,Balchi Mohamad,Abdallah Yana,Nooryani Arif Al

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. ANMCO POSITION PAPER: role of intra-aortic balloon pump in patients with acute advanced heart failure and cardiogenic shock;Rossini;Eur Heart J Suppl,2021

2. Decade-long trends (2001–2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction;Goldberg;Circ Cardiovasc Qual Outcomes,2016

3. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intra-aortic balloon pumping for treatment of cardiogenic shock;Burkhoff;Am Heart J.,2006

4. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction;Seyfarth;J Am Coll Cardiol,2008

5. Alushi B, Douedari A, Froehlig G, Knie W, Wurster T, Leistner D, et al. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. 2019;6(1).